Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000036.xml
Laryngorhinootologie 2024; 103(07): 525-528
DOI: 10.1055/a-2308-8400
DOI: 10.1055/a-2308-8400
Gutachten und Recht
Aus der Gutachtenpraxis: Stimmstörungen nach COVID ohne Intubation oder Tracheotomie – Fakt oder Fiktion? [*]
From the Expert’s Office: Voice disorders after COVID without intubation or tracheostomy – fact or fiction?
Hintergrund
In unserer phoniatrischen Poliklinik werden immer wieder Patienten vorstellig, die über Dysphonien nach COVID klagen, ohne jeweils intubiert oder tracheotomiert worden zu sein.
* auszugsweise vorgetragen anlässlich der Jahrestagung der Vereinigung Westdeutscher Hals-Nasen-Ohren-Ärzte, Köln, 08.03.–09.03.2024 (https://www.egms.de/en/meetings/wdhno2024/24wdhno21.shtml – doi:10.3205/24wdhno21)
Publication History
Article published online:
02 July 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Koczulla AR, Ankermann T, Behrends U. et al. S1-Leitlinie Long-/Post-COVID. Pneumologie 2022; 76: 855-907 DOI: 10.1055/a-1946-3230.
- 2 Flatau TS. Die funktionelle Stimmschwäche (Phonasthenie) der Sänger, Sprecher und Kommandorufer. Charlottenburg: Bürkner 1906.
- 3 Shahpasand S, Olthoff A, Beutner D. Dysphonie als Post-Covid-Syndrom?. Laryngo-Rhino-Otologie 2022; 101: 147 DOI: 10.1055/s-0042-1747551.
- 4 Lechien JR, Chiesa-Estomba CM, Cabaraux P. et al. Features of mild-to-moderate COVID-19 patients with dysphonia. J Voice 2022; 36: 249-255 DOI: 10.1016/j.jvoice.2020.05.012.
- 5 Lin CW, Wang YH, Li YE. et al. COVID-related dysphonia and persistent Long-COVID voice sequelae: A systematic review and meta-analysis. Am J Otolaryngol 2023; 44: 103950 DOI: 10.1016/j.amjoto.2023.103950.
- 6 Lladós G, Massanella M, Coll-Fernández R. et al. Vagus nerve dysfunction in the Post-COVID-19 condition: A pilot cross-sectional study. Clin Microbiol Infect 2024; 30: 515-521 DOI: 10.1016/j.cmi.2023.11.007.
- 7 Al-Ani RM, Rashid RA. Prevalence of dysphonia due to COVID-19 at Salahaddin General Hospital, Tikrit City, Iraq. Am J Otolaryngol 2021; 42: 103157 DOI: 10.1016/j.amjoto.2021.103157.
- 8 Azzam AAA, Samy A, Sefein I. et al. Vocal disorders in patients with COVID 19 in Egypt. Indian J Otolaryngol Head Neck Surg 2022; 74: 3420-3426 DOI: 10.1007/s12070-021-02663-0.
- 9 Farr E, Wolfe AR, Deshmukh S. et al. Diaphragm dysfunction in severe COVID-19 as determined by neuromuscular ultrasound. Ann Clin Transl Neurol 2021; 8: 1745-1749 DOI: 10.1002/acn3.51416.
- 10 Spiesshoefer J, Friedrich J, Regmi B. et al. Diaphragm dysfunction as a potential determinant of dyspnea on exertion in patients 1 year after COVID-19-related ARDS. Respir Res 2022; 23: 187 DOI: 10.1186/s12931-022-02100-y.
- 11 Papadopoulou M, Bakola E, Papapostolou A. et al. Autonomic dysfunction entwined with post-COVID but absent in non-post-COVID patients: A neurophysiological and neurosonology study. Ther Adv Neurol Disord 2023; 16: 1-5 DOI: 10.1177/17562864231180711.
- 12 Papadopoulou M, Bakola E, Papapostolou A. et al. Autonomic dysfunction in Long-COVID syndrome: A neurophysiological and neurosonology study. J Neurol 2022; 269: 4611-4612 DOI: 10.1007/s00415-022-11172-1.
- 13 Woo MS, Shafiq M, Fitzek A. et al. Vagus nerve inflammation contributes to dysautonomia in COVID-19. Acta Neuropathol 2023; 146: 387-394 DOI: 10.1007/s00401-023-02612-x.
- 14 Wong AC, Devason AS, Umana IC. et al. Serotonin reduction in post-acute sequelae of viral infection. Cell 2023; 186: 4851-4867 DOI: 10.1016/j.cell.2023.09.013.
- 15 Offord C. Low serotonin levels might explain some Long Covid symptoms, study proposes. Im Internet: (16.10.2023); Zugriff am 10.04.2024 https://www.science.org/content/article/low-serotonin-levels-might-explain-some-long-covid-symptoms-study-proposes
- 16 Jeleniewska J, Niebudek-Bogusz E, Malinowski J. et al. Isolated severe dysphonia as a presentation of Post-COVID-19 syndrome. Diagnostics 2022; 12: 1839 DOI: 10.3390/diagnostics12081839.
- 17 Tornero C, Pastor E, Garzando MDM. et al. Non-invasive vagus nerve stimulation for COVID-19: Results from a randomized controlled trial (SAVIOR I). Front Neurol 2022; 13: 820864 DOI: 10.3389/fneur.2022.820864.
- 18 Badran BW, Huffman SM, Dancy M. et al. A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular Vagus Nerve Stimulation (taVNS) to manage Long COVID symptoms. Bioelectron Med 2022; 8: 13 DOI: 10.1186/s42234-022-00094-y.